-
Symbol
-
RNTX on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.001 par value
-
Latest Disclosed Shares Owned
-
3,683,429 shares
-
Security Ownership %
-
6.2%
BIOS EQUITY PARTNERS III, LP ownership in Rein Therapeutics, Inc. Common Stock, $0.001 par value (RNTX)
11 Aug 2025 - BIOS EQUITY PARTNERS III, LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,683,429 shares of Rein Therapeutics, Inc. Common Stock, $0.001 par value (RNTX).
This represents 6.2% ownership of the company.
This is the first filing by BIOS Fund III, LP disclosing ownership of Rein Therapeutics, Inc. Common Stock, $0.001 par value (RNTX).